{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:26:49Z","timestamp":1793917609616,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00734-2","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:30:24Z","timestamp":1775698224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TYMP upregulation mediated by the hyperactivated IL-17\/NF-\u03baB1 axis promotes psoriasis through enhancing aberrant keratinization and neutrophil-mediated inflammation"],"prefix":"10.1186","volume":"21","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"10281","key":"734_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J, Psoriasis. Lancet (London England). 2021;397(10281):1301\u201315.","journal-title":"Lancet (London England)"},{"issue":"3","key":"734_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40291-025-00776-8","volume":"29","author":"Y Pan","year":"2025","unstructured":"Pan Y, Zou J, Hu T, Zhu Z, Zhang Z, Chen W, et al. Psoriasis: A multidimensional review of Onset, Progression, Treatment, and the evolution of disease models. Mol Diagn Ther. 2025;29(3):345\u201366.","journal-title":"Mol Diagn Ther"},{"key":"734_CR3","doi-asserted-by":"publisher","first-page":"122991","DOI":"10.1016\/j.lfs.2024.122991","volume":"355","author":"D Sugumaran","year":"2024","unstructured":"Sugumaran D, Yong ACH, Stanslas J. Advances in psoriasis research: from pathogenesis to therapeutics. Life Sci. 2024;355:122991.","journal-title":"Life Sci"},{"issue":"2","key":"734_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ijd.17497","volume":"64","author":"S Amara","year":"2025","unstructured":"Amara S, Pasumarthi A, Parikh N, Kodali N, Lebwohl M, Monks G. Psoriasis management tree based on comorbidity. Int J Dermatol. 2025;64(2):229\u201345.","journal-title":"Int J Dermatol"},{"issue":"1","key":"734_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Blauvelt A, Callis Duffin K, Huang YH, Savage LJ, Guo L, et al. Psoriasis Nat Reviews Disease Primers. 2025;11(1):45.","journal-title":"Psoriasis Nat Reviews Disease Primers"},{"issue":"1","key":"734_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-025-07521-3","volume":"16","author":"C Huang","year":"2025","unstructured":"Huang C, Li W, Shen C, Jiang B, Zhang K, Li X, et al. YAP1 facilitates the pathogenesis of psoriasis via modulating keratinocyte proliferation and inflammation. Cell Death Dis. 2025;16(1):186.","journal-title":"Cell Death Dis"},{"issue":"1","key":"734_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41419-025-07358-w","volume":"16","author":"P Lian","year":"2025","unstructured":"Lian P, Li L, Lu R, Zhang B, Wazir J, Gu C, et al. S1PR3-driven positive feedback loop sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis. Cell Death Dis. 2025;16(1):31.","journal-title":"Cell Death Dis"},{"key":"734_CR8","doi-asserted-by":"publisher","first-page":"139210","DOI":"10.1016\/j.ijbiomac.2024.139210","volume":"291","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qin L, Li X, Wang L, Ling G, Zhang P. Dual-strategy microneedles of bio\u2013oxygen therapy and artificial enzyme anti-oxidation for psoriasis treatment. Int J Biol Macromol. 2025;291:139210.","journal-title":"Int J Biol Macromol"},{"key":"734_CR9","doi-asserted-by":"publisher","first-page":"adv42794","DOI":"10.2340\/actadv.v105.42794","volume":"105","author":"C Spitzer","year":"2025","unstructured":"Spitzer C, Buchholz I, L\u00fcbke L, W\u00fclfing C, Meier K, Kokolakis G, et al. Determinants of quality of life in patients with atopic dermatitis and psoriasis: A multivariate approach. Acta dermato-venereologica. 2025;105:adv42794.","journal-title":"Acta dermato-venereologica"},{"issue":"Suppl 4","key":"734_CR10","first-page":"553","volume":"32","author":"V Bulat","year":"2020","unstructured":"Bulat V, \u0160itum M, Dela\u0161 A\u017edaji\u0107 M, Lovri\u0107 I, Dediol I. Study on the impact of psoriasis on quality of life: Psychological, social and financial implications. Psychiatria Danubina. 2020;32(Suppl 4):553\u201361.","journal-title":"Psychiatria Danubina"},{"key":"734_CR11","doi-asserted-by":"publisher","first-page":"110347","DOI":"10.1016\/j.jpsychores.2020.110347","volume":"141","author":"M Pompili","year":"2021","unstructured":"Pompili M, Bonanni L, Gualtieri F, Trovini G, Persechino S, Baldessarini RJ. Suicidal risks with psoriasis and atopic dermatitis: systematic review and meta-analysis. J Psychosom Res. 2021;141:110347.","journal-title":"J Psychosom Res"},{"issue":"3","key":"734_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41419-024-06583-z","volume":"15","author":"D Guo","year":"2024","unstructured":"Guo D, Li X, Wang J, Liu X, Wang Y, Huang S, et al. Single-cell RNA-seq reveals keratinocyte and fibroblast heterogeneity and their crosstalk via epithelial-mesenchymal transition in psoriasis. Cell Death Dis. 2024;15(3):207.","journal-title":"Cell Death Dis"},{"issue":"2","key":"734_CR13","first-page":"e79097","volume":"17","author":"SF Qasem","year":"2025","unstructured":"Qasem SF, Ashkanani H, Ali A. Therapeutic advancements in the management of psoriasis: A clinical overview and update. Cureus. 2025;17(2):e79097.","journal-title":"Cureus"},{"issue":"Pt 1","key":"734_CR14","doi-asserted-by":"publisher","first-page":"113388","DOI":"10.1016\/j.intimp.2024.113388","volume":"143","author":"F Ferrara","year":"2024","unstructured":"Ferrara F, Verduci C, Laconi E, Mangione A, Dondi C, Del Vecchio M, et al. Current therapeutic overview and future perspectives regarding the treatment of psoriasis. Int Immunopharmacol. 2024;143(Pt 1):113388.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"734_CR15","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1038\/s41467-022-34323-4","volume":"13","author":"MT Patrick","year":"2022","unstructured":"Patrick MT, Li Q, Wasikowski R, Mehta N, Gudjonsson JE, Elder JT, et al. Shared genetic risk factors and causal association between psoriasis and coronary artery disease. Nat Commun. 2022;13(1):6565.","journal-title":"Nat Commun"},{"key":"734_CR16","doi-asserted-by":"publisher","first-page":"113626","DOI":"10.1016\/j.intimp.2024.113626","volume":"144","author":"SJ Kshirsagar","year":"2025","unstructured":"Kshirsagar SJ, Adhav PS, Laddha UD, Ganore JS, Pagar CS, Bambal VR. Navigating psoriasis: from immune mechanisms to natural healing approaches. Int Immunopharmacol. 2025;144:113626.","journal-title":"Int Immunopharmacol"},{"issue":"10275","key":"734_CR17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet (London England). 2021;397(10275):754\u201366.","journal-title":"Lancet (London England)"},{"key":"734_CR18","doi-asserted-by":"crossref","unstructured":"Jiang Y, Tsoi LC, Billi AC, Ward NL, Harms PW, Zeng C, et al. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight. 2020;5(20).","DOI":"10.1172\/jci.insight.142067"},{"key":"734_CR19","doi-asserted-by":"crossref","unstructured":"Ye J, Lai Y. Keratinocytes: new perspectives in inflammatory skin diseases. Trends Mol Med. 2025;31(12):1103\u201313.","DOI":"10.1016\/j.molmed.2025.03.012"},{"issue":"2","key":"734_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The immunology of Psoriasis-Current concepts in pathogenesis. Clin Rev Allergy Immunol. 2024;66(2):164\u201391.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"734_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/1753425919852156","volume":"25","author":"M Furue","year":"2019","unstructured":"Furue M, Kadono T. The contribution of IL-17 to the development of autoimmunity in psoriasis. Innate Immun. 2019;25(6):337\u201343.","journal-title":"Innate Immun"},{"issue":"8","key":"734_CR22","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1080\/09546634.2022.2114288","volume":"33","author":"A Norden","year":"2022","unstructured":"Norden A, Oulee A, Munawar L, Javadi SS, Han G, Wu JJ. Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review. J Dermatolog Treat. 2022;33(8):3080\u20135.","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"734_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cei.13449","volume":"201","author":"JM Fletcher","year":"2020","unstructured":"Fletcher JM, Moran B, Petrasca A, Smith CM. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol. 2020;201(2):121\u201334.","journal-title":"Clin Exp Immunol"},{"key":"734_CR24","doi-asserted-by":"crossref","unstructured":"Palazzo E, Lotti R, Quadri M, Pincelli C, Marconi A. IL-17 ligand and receptor family members are differentially expressed by keratinocyte subpopulations and modulate their differentiation and inflammatory phenotype. Int J Mol Sci. 2025;26(7).","DOI":"10.3390\/ijms26072989"},{"issue":"9","key":"734_CR25","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jid.2022.02.016","volume":"142","author":"Z Yu","year":"2022","unstructured":"Yu Z, Yu Q, Xu H, Dai X, Yu Y, Cui L, et al. IL-17A promotes Psoriasis-Associated keratinocyte proliferation through ACT1-Dependent activation of YAP-AREG axis. J Invest Dermatol. 2022;142(9):2343\u201352.","journal-title":"J Invest Dermatol"},{"key":"734_CR26","doi-asserted-by":"publisher","first-page":"117217","DOI":"10.1016\/j.taap.2024.117217","volume":"495","author":"B Cai","year":"2025","unstructured":"Cai B, He Z, Liu D, Zhang Y, Yin Z, Bao W, et al. Thymidine phosphorylase participates in platelet activation and promotes inflammation in rheumatoid arthritis. Toxicol Appl Pharmcol. 2025;495:117217.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"12","key":"734_CR27","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1007\/s12031-021-01822-w","volume":"71","author":"H Mojtabavi","year":"2021","unstructured":"Mojtabavi H, Fatehi F, Shahkarami S, Rezaei N, Nafissi S. Novel mutations of the TYMP gene in mitochondrial neurogastrointestinal encephalomyopathy: case series and literature review. J Mol Neuroscience: MN. 2021;71(12):2526\u201333.","journal-title":"J Mol Neuroscience: MN"},{"key":"734_CR28","doi-asserted-by":"publisher","first-page":"153303382311945","DOI":"10.1177\/15330338231194555","volume":"22","author":"SA Chen","year":"2023","unstructured":"Chen SA, Zhang JP, Wang N, Chen J. Identifying TYMP as an immune prognostic marker in clear cell renal cell carcinoma. Technol Cancer Res Treat. 2023;22:15330338231194555.","journal-title":"Technol Cancer Res Treat"},{"key":"734_CR29","doi-asserted-by":"publisher","first-page":"217307","DOI":"10.1016\/j.canlet.2024.217307","volume":"606","author":"M Malier","year":"2024","unstructured":"Malier M, Laverriere MH, Henry M, Yakoubi M, Bellaud P, Arellano C, et al. Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine\/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase. Cancer Lett. 2024;606:217307.","journal-title":"Cancer Lett"},{"key":"734_CR30","doi-asserted-by":"publisher","first-page":"1561560","DOI":"10.3389\/fimmu.2025.1561560","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang B, Yuan Q, Sun J, Wang C, Yang D. Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy. Front Immunol. 2025;16:1561560.","journal-title":"Front Immunol"},{"issue":"10","key":"734_CR31","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00109-023-02358-9","volume":"101","author":"J Du","year":"2023","unstructured":"Du J, Zhang C, Liu F, Liu X, Wang D, Zhao D, et al. Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction. J Mol Med. 2023;101(10):1237\u201353.","journal-title":"J Mol Med"},{"issue":"1","key":"734_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-022-02296-2","volume":"20","author":"J Gautheron","year":"2022","unstructured":"Gautheron J, Lima L, Akinci B, Zammouri J, Auclair M, Ucar SK, et al. Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes. BMC Med. 2022;20(1):95.","journal-title":"BMC Med"},{"issue":"2","key":"734_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/1523-1747.ep12480547","volume":"97","author":"C Hammerberg","year":"1991","unstructured":"Hammerberg C, Fisher GJ, Voorhees JJ, Cooper KD. Elevated thymidine phosphorylase activity in psoriatic lesions accounts for the apparent presence of an epidermal growth inhibitor, but is not in itself growth inhibitory. J Invest Dermatol. 1991;97(2):286\u201390.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"734_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1046\/j.1365-2133.1997.19772089.x","volume":"137","author":"D Creamer","year":"1997","unstructured":"Creamer D, Jaggar R, Allen M, Bicknell R, Barker J. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor\/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol. 1997;137(6):851\u20135.","journal-title":"Br J Dermatol"},{"issue":"1","key":"734_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41419-025-08029-6","volume":"16","author":"D Li","year":"2025","unstructured":"Li D, Zhou Z, Li X, Guo Q, Yuan L, Zhang X, et al. Hypermethylation-mediated HNF4A Silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell Polarity and activating EMT signaling. Cell Death Dis. 2025;16(1):688.","journal-title":"Cell Death Dis"},{"issue":"1","key":"734_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41419-025-07464-9","volume":"16","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li D, Ma H, Li Z, Wu J, Qiao J, et al. Tumor cell-derived EMP1 is essential for cancer-associated fibroblast infiltration in tumor microenvironment of triple-negative breast cancer. Cell Death Dis. 2025;16(1):143.","journal-title":"Cell Death Dis"},{"issue":"Pt 3","key":"734_CR37","doi-asserted-by":"publisher","first-page":"137565","DOI":"10.1016\/j.ijbiomac.2024.137565","volume":"283","author":"L Xia","year":"2024","unstructured":"Xia L, Wang H, Du G, Cheng X, Zhang R, Yu H, et al. Receptor accessory protein 6, a novel ferroptosis suppressor, drives oral squamous cell carcinoma by maintaining Endoplasmic reticulum hemostasis. Int J Biol Macromol. 2024;283(Pt 3):137565.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"734_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41419-024-06744-0","volume":"15","author":"S Qin","year":"2024","unstructured":"Qin S, Guo Q, Liu Y, Zhang X, Huang P, Yu H, et al. A novel TGFbeta\/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression. Cell Death Dis. 2024;15(5):368.","journal-title":"Cell Death Dis"},{"issue":"1","key":"734_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-024-03103-x","volume":"43","author":"S Qin","year":"2024","unstructured":"Qin S, Liu Y, Zhang X, Huang P, Xia L, Leng W, et al. LncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1. J Experimental Clin Cancer Research: CR. 2024;43(1):188.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"5","key":"734_CR40","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","volume":"148","author":"J Kim","year":"2021","unstructured":"Kim J, Lee J, Kim HJ, Kameyama N, Nazarian R, Der E, et al. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. J Allergy Clin Immunol. 2021;148(5):1281\u201392.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"734_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41419-021-03724-6","volume":"12","author":"Y Gao","year":"2021","unstructured":"Gao Y, Yao X, Zhai Y, Li L, Li H, Sun X, et al. Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells. Cell Death Dis. 2021;12(5):450.","journal-title":"Cell Death Dis"},{"key":"734_CR42","doi-asserted-by":"crossref","unstructured":"van Straalen KR, Ma F, Tsou PS, Plazyo O, Gharaee-Kermani M, Calbet M, et al. Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa. J Clin Investig. 2024;134(3).","DOI":"10.1172\/JCI169225"},{"issue":"2","key":"734_CR43","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.apsb.2024.12.041","volume":"15","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhao L, Yan W, Ma H, Zhao W, Qu J, et al. Celastrol directly targets LRP1 to inhibit fibroblast-macrophage crosstalk and ameliorates psoriasis progression. Acta Pharm Sinica B. 2025;15(2):876\u201391.","journal-title":"Acta Pharm Sinica B"},{"key":"734_CR44","doi-asserted-by":"publisher","first-page":"110328","DOI":"10.1016\/j.clim.2024.110328","volume":"266","author":"L Peng","year":"2024","unstructured":"Peng L, Liu W, Cheng Y, Chen L, Shen Z. IL-17A\/F double producing T cells, unstable Tregs and quiescent TRMs in clinically healed lesions are potential cellular candidates for recurrence of psoriasis. Clin Immunol (Orlando Fla). 2024;266:110328.","journal-title":"Clin Immunol (Orlando Fla)"},{"issue":"D1","key":"734_CR45","doi-asserted-by":"publisher","first-page":"D932","DOI":"10.1093\/nar\/gkae1108","volume":"53","author":"M Li","year":"2025","unstructured":"Li M, Ang KS, Teo B, Rom U, Nguyen MN, Maurer-Stroh S, et al. Rediscovering publicly available single-cell data with the DISCO platform. Nucleic Acids Res. 2025;53(D1):D932\u20138.","journal-title":"Nucleic Acids Res"},{"key":"734_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fonc.2019.00220","volume":"9","author":"D Li","year":"2019","unstructured":"Li D, Cheng P, Wang J, Qiu X, Zhang X, Xu L, et al. IRF6 is directly regulated by ZEB1 and ELF3, and predicts a favorable prognosis in gastric cancer. Front Oncol. 2019;9:220.","journal-title":"Front Oncol"},{"key":"734_CR47","doi-asserted-by":"publisher","first-page":"955841","DOI":"10.3389\/fimmu.2022.955841","volume":"13","author":"S Qin","year":"2022","unstructured":"Qin S, Wang Z, Huang C, Huang P, Li D. Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2. Front Immunol. 2022;13:955841.","journal-title":"Front Immunol"},{"issue":"1","key":"734_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41420-023-01336-x","volume":"9","author":"D Li","year":"2023","unstructured":"Li D, Xia L, Huang P, Wang Z, Guo Q, Huang C, et al. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2\/FGFR1\/PI3K\/AKT axis. Cell Death Discov. 2023;9(1):17.","journal-title":"Cell Death Discov"},{"key":"734_CR49","doi-asserted-by":"crossref","unstructured":"Li DD, Zhou Z, Hui YJ, Yu HD, Ren T, Zhai LT, et al. EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial-mesenchymal phenotypes due to an inflammatory microenvironment. Exp Mol Med. 2025.","DOI":"10.1038\/s12276-025-01570-6"},{"issue":"65","key":"734_CR50","doi-asserted-by":"publisher","first-page":"eabi8823","DOI":"10.1126\/sciimmunol.abi8823","volume":"6","author":"RK Gupta","year":"2021","unstructured":"Gupta RK, Gracias DT, Figueroa DS, Miki H, Miller J, Fung K, et al. TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy. Sci Immunol. 2021;6(65):eabi8823.","journal-title":"Sci Immunol"},{"issue":"1","key":"734_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","volume":"130","author":"JG Krueger","year":"2012","unstructured":"Krueger JG, Fretzin S, Su\u00e1rez-Fari\u00f1as M, Haslett PA, Phipps KM, Cameron GS, et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol. 2012;130(1):145\u2013e549.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"734_CR52","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1016\/S1470-2045(12)70426-6","volume":"13","author":"GJ Peters","year":"2012","unstructured":"Peters GJ, Bijnsdorp IV. TAS-102: more than an antimetabolite. Lancet Oncol. 2012;13(12):e518\u20139.","journal-title":"Lancet Oncol"},{"issue":"3","key":"734_CR53","doi-asserted-by":"publisher","first-page":"adv00032","DOI":"10.2340\/00015555-3386","volume":"100","author":"C Reid","year":"2020","unstructured":"Reid C, Griffiths CEM. Psoriasis and treatment: Past, present and future aspects. Acta dermato-venereologica. 2020;100(3):adv00032.","journal-title":"Acta dermato-venereologica"},{"issue":"11","key":"734_CR54","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jid.2019.08.437","volume":"139","author":"AC Billi","year":"2019","unstructured":"Billi AC, Gudjonsson JE, Voorhees JJ, Psoriasis. Past, Present, and future. J Invest Dermatol. 2019;139(11):e133\u201342.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"734_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00438-021-01804-y","volume":"296","author":"Y Luo","year":"2021","unstructured":"Luo Y, Qu K, Kuai L, Ru Y, Huang K, Yan X, et al. Epigenetics in psoriasis: perspective of DNA methylation. Mol Genet Genomics: MGG. 2021;296(5):1027\u201340.","journal-title":"Mol Genet Genomics: MGG"},{"issue":"1","key":"734_CR56","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1038\/s41467-025-56719-8","volume":"16","author":"N Dand","year":"2025","unstructured":"Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, et al. GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Nat Commun. 2025;16(1):2051.","journal-title":"Nat Commun"},{"key":"734_CR57","doi-asserted-by":"crossref","unstructured":"Nakamizo S, Dutertre CA, Khalilnezhad A, Zhang XM, Lim S, Lum J, et al. Single-cell analysis of human skin identifies CD14\u2009+\u2009type 3 dendritic cells co-producing IL1B and IL23A in psoriasis. J Exp Med. 2021;218(9).","DOI":"10.1084\/jem.20202345"},{"issue":"1","key":"734_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13(1):81.","journal-title":"Cell Death Dis"},{"issue":"9","key":"734_CR59","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41419-023-06094-3","volume":"14","author":"N Lian","year":"2023","unstructured":"Lian N, Chen Y, Chen S, Zhang Y, Chen H, Yang Y, et al. Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis. Cell Death Dis. 2023;14(9):595.","journal-title":"Cell Death Dis"},{"issue":"3","key":"734_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2015.12.009","volume":"81","author":"P Lovato","year":"2016","unstructured":"Lovato P, Norsgaard H, Tokura Y, R\u00f8pke MA. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. J Dermatol Sci. 2016;81(3):153\u201364.","journal-title":"J Dermatol Sci"},{"issue":"Pt 6","key":"734_CR61","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/brain\/awv077","volume":"138","author":"C Chapouly","year":"2015","unstructured":"Chapouly C, Tadesse Argaw A, Horng S, Castro K, Zhang J, Asp L, et al. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. Brain. 2015;138(Pt 6):1548\u201367.","journal-title":"Brain"},{"issue":"8","key":"734_CR62","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519\u201331.","journal-title":"Nat Rev Immunol"},{"key":"734_CR63","doi-asserted-by":"publisher","first-page":"102680","DOI":"10.1016\/j.coi.2025.102680","volume":"97","author":"Y Matsushima","year":"2025","unstructured":"Matsushima Y, Hwang ST, Simon SI. Mechanobiology of neutrophil inflammasome signaling in psoriasis. Curr Opin Immunol. 2025;97:102680.","journal-title":"Curr Opin Immunol"},{"key":"734_CR64","doi-asserted-by":"crossref","unstructured":"Jiang R, Kirma J, Fox J, Xing X, Wang J, Sarkar MK, et al. Dynamic neutrophil-keratinocyte communication network centered on IL-36\/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis. Nat Commun. 2025;17(1):1156.","DOI":"10.1038\/s41467-025-67917-9"},{"issue":"8","key":"734_CR65","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41423-025-01296-5","volume":"22","author":"T Xia","year":"2025","unstructured":"Xia T, Zhang W, Wu R, Zhang X, Xia R, Hu X, et al. Dermal adipogenesis protects against neutrophilic skin inflammation during psoriasis pathogenesis. Cell Mol Immunol. 2025;22(8):901\u201317.","journal-title":"Cell Mol Immunol"},{"key":"734_CR66","doi-asserted-by":"crossref","unstructured":"Czerwi\u0144ska J, Owczarczyk-Saczonek A. The role of the neutrophilic network in the pathogenesis of psoriasis. Int J Mol Sci. 2022;23(3).","DOI":"10.3390\/ijms23031840"},{"issue":"7","key":"734_CR67","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/srt.13404","volume":"29","author":"Z Wang","year":"2023","unstructured":"Wang Z, Shi D. Research progress on the neutrophil components and their interactions with immune cells in the development of psoriasis. Skin Res Technology: Official J Int Soc Bioeng Skin (ISBS) [and] Int Soc Digit Imaging Skin (ISDIS) [and] Int Soc Skin Imaging (ISSI). 2023;29(7):e13404.","journal-title":"Skin Res Technology: Official J Int Soc Bioeng Skin (ISBS) [and] Int Soc Digit Imaging Skin (ISDIS) [and] Int Soc Skin Imaging (ISSI)"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00734-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:52:52Z","timestamp":1775710372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00734-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00734-2","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee of Hubei University of Medicine (SYSRMYY-020), in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}